Non-Hodgkin	O
's	O
lymphoma	O
involving	O
bilateral	O
breasts	O
[	O
see	O
comments	O
]	O

We	O
describe	O
here	O
two	O
cases	O
of	O
diffuse	O
large	O
cell	O
type	O
non-Hodgkin	O
's	O
lymphoma	O
affecting	O
the	O
bilateral	O
breasts	O
.	O

The	O
contralateral	O
tumor	O
in	O
one	O
case	O
appeared	O
17	O
months	O
after	O
the	O
first	O
mastectomy	O
,	O
whereas	O
the	O
bilateral	O
tumors	O
occurred	O
concurrently	O
in	O
the	O
other	O
patient	O
who	O
was	O
pregnant	O
and	O
showed	O
widespread	O
dissemination	O
at	O
initial	O
presentation	O
.	O

Lymphoma	B-cell_type
cells	I-cell_type
from	O
both	O
cases	O
showed	O
the	O
mature	O
B-cell	O
immunophenotype	O
and	O
had	O
rearrangements	O
of	O
the	O
BCL6	B-DNA
gene	I-DNA
.	O

Both	O
patients	O
developed	O
progressive	O
disease	O
despite	O
chemo-radiotherapy	O
and	O
died	O
of	O
leukemic	O
manifestations	O
.	O

There	O
were	O
no	O
apparent	O
pathological	O
features	O
of	O
lymphomas	O
of	O
mucosa-associated	O
lymphoid	O
tissue	O
origin	O

0	NULL
CASE	NULL
REPORT	NULL
OQ	NULL
Non-Hodgkin	NULL
's	NULL
Lymphoma	NULL
Involving	NULL
Bilateral	NULL
Breasts	NULL
Toshio	NULL
Krrawakt	NULL
,	NULL
Noboru	NULL
YonETANI	NULL
,	NULL
Hiroshi	NULL
AKasaka	NULL
,	NULL
Takashi	NULL
Axasaka	NULL
,	NULL
Hitoshi	NULL
Ono	NULL
and	NULL
Minoru	NULL
OKuUmMa	NULL
We	NULL
describe	NULL
here	NULL
two	NULL
cases	NULL
of	NULL
diffuse	NULL
large	NULL
cell	NULL
type	NULL
non-Hodgkin	NULL
's	NULL
lymphoma	NULL
affecting	NULL
the	NULL
bilateral	NULL
breasts	NULL
.	NULL

The	NULL
contralateral	NULL
tumor	NULL
in	NULL
one	NULL
case	NULL
appeared	NULL
17	NULL
months	NULL
after	NULL
the	NULL
first	NULL
mastectomy	NULL
,	NULL
whereas	NULL
the	NULL
bilateral	NULL
tumors	NULL
occurred	NULL
concurrently	NULL
in	NULL
the	NULL
other	NULL
patient	NULL
who	NULL
was	NULL
pregnant	NULL
and	NULL
showed	NULL
widespread	NULL
dissemination	NULL
at	NULL
initial	NULL
presentation	NULL
.	NULL

Lymphoma	NULL
cells	NULL
from	NULL
both	NULL
cases	NULL
showed	NULL
the	NULL
mature	NULL
B-cell	NULL
immunophenotype	NULL
and	NULL
had	NULL
rearrangements	NULL
of	NULL
the	NULL
BCLG	NULL
gene	NULL
.	NULL

Both	NULL
patients	NULL
developed	NULL
progressive	NULL
disease	NULL
despite	NULL
chemo-radiotherapy	NULL
and	NULL
died	NULL
of	NULL
leukemic	NULL
manifes-tations	NULL
.	NULL

There	NULL
were	NULL
no	NULL
apparent	NULL
pathological	NULL
features	NULL
of	NULL
lymphomas	NULL
of	NULL
mucosa-associated	NULL
lymphoid	NULL
tissue	NULL
origin	NULL
.	NULL

(	NULL
Internal	NULL
Medicine	NULL
37	NULL
:	NULL
311-315	NULL
,	NULL
1998	NULL
)	NULL
Key	NULL
words	NULL
:	NULL
-	NULL
primary	NULL
breast	NULL
lymphoma	NULL
,	NULL
diffuse	NULL
large	NULL
cell	NULL
lymphoma	NULL
,	NULL
B-cell	NULL
phenotype	NULL
,	NULL
oncogene	NULL
,	NULL
BCL6	NULL
gene	NULL
,	NULL
mucosa-associated	NULL
lymphoid	NULL
tissue	NULL
Introduction	NULL
Non-Hodgkin	NULL
's	NULL
lymphoma	NULL
(	NULL
NHL	NULL
)	NULL
of	NULL
the	NULL
breast	NULL
(	NULL
primary	NULL
breast	NULL
lymphoma	NULL
,	NULL
PBL	NULL
)	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
comprise	NULL
0.04	NULL
%	NULL
to	NULL
0.5	NULL
%	NULL
of	NULL
all	NULL
malignant	NULL
diseases	NULL
of	NULL
the	NULL
breast	NULL
and	NULL
1.7	NULL
%	NULL
to	NULL
2.2	NULL
%	NULL
of	NULL
extranodal	NULL
NHL	NULL
s	NULL
in	NULL
Western	NULL
countries	NULL
(	NULL
1-3	NULL
)	NULL
.	NULL

In	NULL
two	NULL
large	NULL
Japanese	NULL
series	NULL
,	NULL
a	NULL
total	NULL
of	NULL
26	NULL
cases	NULL
with	NULL
PBL	NULL
have	NULL
been	NULL
reported	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

The	NULL
majority	NULL
of	NULL
these	NULL
cases	NULL
showed	NULL
diffuse	NULL
large	NULL
cell	NULL
histopathology	NULL
and	NULL
immunohistochemical	NULL
analysis	NULL
revealed	NULL
that	NULL
the	NULL
lymphoma	NULL
cells	NULL
almost	NULL
invariably	NULL
had	NULL
the	NULL
B-cell	NULL
phenotype	NULL
.	NULL

Of	NULL
the	NULL
26	NULL
cases	NULL
,	NULL
two	NULL
had	NULL
a	NULL
bilateral	NULL
disease	NULL
and	NULL
Jeon	NULL
et	NULL
al	NULL
(	NULL
5	NULL
)	NULL
suggested	NULL
a	NULL
distinctive	NULL
subgroup	NULL
of	NULL
PBL	NULL
affecting	NULL
the	NULL
bilateral	NULL
breasts	NULL
in	NULL
younger	NULL
women	NULL
.	NULL

In	NULL
the	NULL
present	NULL
report	NULL
,	NULL
we	NULL
describe	NULL
two	NULL
patients	NULL
with	NULL
PBL	NULL
involving	NULL
the	NULL
bilateral	NULL
breasts	NULL
.	NULL

The	NULL
clinical	NULL
behavior	NULL
,	NULL
immunophenotype	NULL
of	NULL
the	NULL
lymphoma	NULL
cells	NULL
and	NULL
the	NULL
state	NULL
of	NULL
oncogenes	NULL
are	NULL
discussed	NULL
.	NULL

For	NULL
editorial	NULL
comment	NULL
,	NULL
see	NULL
also	NULL
p	NULL
233	NULL
.	NULL

Case	NULL
Report	NULL
Case	NULL
1	NULL
(	NULL
#	NULL
849	NULL
)	NULL
The	NULL
patient	NULL
was	NULL
a	NULL
42-year-old	NULL
Japanese	NULL
woman	NULL
who	NULL
had	NULL
noticed	NULL
a	NULL
lump	NULL
in	NULL
the	NULL
right	NULL
breast	NULL
in	NULL
July	NULL
1993	NULL
.	NULL

She	NULL
was	NULL
referred	NULL
to	NULL
the	NULL
surgery	NULL
department	NULL
and	NULL
underwent	NULL
modified	NULL
radical	NULL
mastectomy	NULL
in	NULL
September	NULL
.	NULL

Microscopic	NULL
examination	NULL
of	NULL
the	NULL
tumor	NULL
,	NULL
which	NULL
was	NULL
5	NULL
cm	NULL
in	NULL
diameter	NULL
,	NULL
revealed	NULL
NHL	NULL
.	NULL

Axillary	NULL
and	NULL
subclavicular	NULL
lymph	NULL
nodes	NULL
were	NULL
negative	NULL
for	NULL
the	NULL
lymphoma	NULL
cells	NULL
.	NULL

She	NULL
was	NULL
referred	NULL
to	NULL
our	NULL
department	NULL
and	NULL
treated	NULL
with	NULL
6	NULL
cycles	NULL
of	NULL
CHOP	NULL
(	NULL
cyclophosphamide	NULL
,	NULL
doxorubicin	NULL
,	NULL
vin-cristine	NULL
and	NULL
prednisolone	NULL
)	NULL
regimen	NULL
.	NULL

In	NULL
April	NULL
1994	NULL
,	NULL
she	NULL
noticed	NULL
nodules	NULL
underneath	NULL
the	NULL
surgical	NULL
scar	NULL
,	NULL
which	NULL
were	NULL
proved	NULL
to	NULL
be	NULL
localized	NULL
recurrence	NULL
.	NULL

She	NULL
was	NULL
treated	NULL
with	NULL
radiotherapy	NULL
followed	NULL
by	NULL
another	NULL
chemotherapy	NULL
regimen	NULL
.	NULL

In	NULL
February	NULL
1995	NULL
,	NULL
however	NULL
,	NULL
her	NULL
left	NULL
breast	NULL
was	NULL
swollen	NULL
and	NULL
a	NULL
left	NULL
axillary	NULL
adenopa-thy	NULL
was	NULL
apparent	NULL
.	NULL

She	NULL
underwent	NULL
a	NULL
second	NULL
mastectomy	NULL
,	NULL
revealing	NULL
the	NULL
relapse	NULL
of	NULL
NHL	NULL
,	NULL
and	NULL
was	NULL
admitted	NULL
to	NULL
our	NULL
department	NULL
thereafter	NULL
.	NULL

On	NULL
examination	NULL
,	NULL
she	NULL
had	NULL
no	NULL
superficial	NULL
lymphade-nopathy	NULL
.	NULL

Liver	NULL
and	NULL
spleen	NULL
were	NULL
not	NULL
felt	NULL
.	NULL

A	NULL
computer-assisted	NULL
tomographic	NULL
(	NULL
CAT	NULL
)	NULL
scan	NULL
of	NULL
the	NULL
body	NULL
merely	NULL
disclosed	NULL
an	NULL
equivocal	NULL
mediastinal	NULL
adenopathy	NULL
.	NULL

However	NULL
,	NULL
examination	NULL
of	NULL
peripheral	NULL
blood	NULL
films	NULL
disclosed	NULL
neoplastic	NULL
cells	NULL
comprising	NULL
20	NULL
%	NULL
to	NULL
30	NULL
%	NULL
of	NULL
total	NULL
nucleated	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
neoplastic	NULL
cells	NULL
infiltrated	NULL
the	NULL
bone	NULL
marrow	NULL
.	NULL

The	NULL
serum	NULL
was	NULL
negative	NULL
for	NULL
anti-human	NULL
T-cell	NULL
lymphotrophic	NULL
virus	NULL
(	NULL
HTLV-I	NULL
)	NULL
antibody	NULL
and	NULL
anti-human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIV	NULL
)	NULL
antibody	NULL
.	NULL

She	NULL
was	NULL
treated	NULL
with	NULL
salvage	NULL
chemotherapy	NULL
protocols	NULL
,	NULL
although	NULL
she	NULL
responded	NULL
transiently	NULL
.	NULL

She	NULL
was	NULL
febrile	NULL
over	NULL
two	NULL
months	NULL
and	NULL
her	NULL
general	NULL
condition	NULL
progressively	NULL
deteriorated	NULL
.	NULL

She	NULL
died	NULL
two	NULL
years	NULL
after	NULL
the	NULL
initial	NULL
presentation	NULL
.	NULL

Case	NULL
2	NULL
(	NULL
#	NULL
910	NULL
)	NULL
The	NULL
patient	NULL
was	NULL
a	NULL
35-year-old	NULL
Japanese	NULL
woman	NULL
who	NULL
had	NULL
noticed	NULL
a	NULL
lump	NULL
in	NULL
the	NULL
right	NULL
breast	NULL
in	NULL
October	NULL
1995	NULL
.	NULL

Because	NULL
she	NULL
was	NULL
pregnant	NULL
at	NULL
that	NULL
time	NULL
,	NULL
she	NULL
was	NULL
reluctant	NULL
to	NULL
be	NULL
referred	NULL
to	NULL
From	NULL
the	NULL
First	NULL
Division	NULL
,	NULL
Department	NULL
of	NULL
Internal	NULL
Medicine	NULL
,	NULL
Faculty	NULL
of	NULL
Medicine	NULL
,	NULL
Kyoto	NULL
University	NULL
,	NULL
Kyoto	NULL
Received	NULL
for	NULL
publication	NULL
June	NULL
16	NULL
,	NULL
1997	NULL
;	NULL
Accepted	NULL
for	NULL
publication	NULL
November	NULL
26	NULL
,	NULL
1997	NULL
Reprint	NULL
requests	NULL
should	NULL
be	NULL
addressed	NULL
to	NULL
Dr.	NULL
Hitoshi	NULL
Ohno	NULL
,	NULL
the	NULL
First	NULL
Division	NULL
,	NULL
Department	NULL
of	NULL
Internal	NULL
Medicine	NULL
,	NULL
Faculty	NULL
of	NULL
Medicine	NULL
,	NULL
Kyoto	NULL
University	NULL
,	NULL
54	NULL
Shogoin-Kawaramachi	NULL
,	NULL
Sakyo-ku	NULL
,	NULL
Kyoto	NULL
606-8507	NULL
Internal	NULL
Medicine	NULL
Vol	NULL
.	NULL

37	NULL
,	NULL
No	NULL
.	NULL

3	NULL
(	NULL
March	NULL
1998	NULL
)	NULL
311	NULL
Krrawakt	NULL
et	NULL
al	NULL
hospital	NULL
.	NULL

However	NULL
,	NULL
the	NULL
breast	NULL
tumor	NULL
grew	NULL
rapidly	NULL
in	NULL
January	NULL
1996	NULL
.	NULL

She	NULL
underwent	NULL
an	NULL
abortion	NULL
and	NULL
was	NULL
referred	NULL
to	NULL
the	NULL
surgery	NULL
department	NULL
.	NULL

On	NULL
examination	NULL
,	NULL
the	NULL
tumor	NULL
of	NULL
the	NULL
right	NULL
breast	NULL
was	NULL
14	NULL
cm	NULL
in	NULL
diameter	NULL
and	NULL
the	NULL
overlying	NULL
skin	NULL
was	NULL
infiltrated	NULL
.	NULL

Several	NULL
tumors	NULL
were	NULL
palpable	NULL
in	NULL
the	NULL
left	NULL
breast	NULL
.	NULL

She	NULL
underwent	NULL
mastectomy	NULL
of	NULL
the	NULL
right	NULL
breast	NULL
and	NULL
biopsy	NULL
of	NULL
the	NULL
left	NULL
breast	NULL
tumor	NULL
.	NULL

Microscopic	NULL
examination	NULL
of	NULL
the	NULL
surgical	NULL
specimens	NULL
revealed	NULL
NHL	NULL
.	NULL

She	NULL
was	NULL
then	NULL
referred	NULL
to	NULL
our	NULL
department	NULL
to	NULL
receive	NULL
chemotherapy	NULL
in	NULL
March	NULL
1996	NULL
.	NULL

On	NULL
examination	NULL
,	NULL
she	NULL
had	NULL
generalized	NULL
superficial	NULL
lymphadenopathy	NULL
as	NULL
well	NULL
as	NULL
tumors	NULL
of	NULL
the	NULL
left	NULL
breast	NULL
.	NULL

Imaging	NULL
studies	NULL
of	NULL
the	NULL
body	NULL
,	NULL
including	NULL
CAT	NULL
scan	NULL
,	NULL
gallium-scintigraphy	NULL
,	NULL
bone	NULL
scan	NULL
and	NULL
magnetic	NULL
resonance	NULL
imaging	NULL
,	NULL
disclosed	NULL
systemic	NULL
enlargement	NULL
of	NULL
lymph	NULL
nodes	NULL
as	NULL
well	NULL
as	NULL
involvement	NULL
of	NULL
the	NULL
bone	NULL
,	NULL
right	NULL
ovary	NULL
and	NULL
cervix	NULL
of	NULL
the	NULL
uterus	NULL
.	NULL

The	NULL
serum	NULL
was	NULL
negative	NULL
for	NULL
anti-HTLV-I	NULL
and	NULL
anti-HIV	NULL
antibodies	NULL
.	NULL

She	NULL
was	NULL
treated	NULL
with	NULL
the	NULL
biweekly	NULL
CHOP	NULL
regimen	NULL
and	NULL
responded	NULL
well	NULL
.	NULL

However	NULL
,	NULL
she	NULL
showed	NULL
right	NULL
facial	NULL
nerve	NULL
palsy	NULL
and	NULL
complained	NULL
of	NULL
severe	NULL
pain	NULL
in	NULL
both	NULL
legs	NULL
.	NULL

Lumbar	NULL
puncture	NULL
disclosed	NULL
lymphoma	NULL
cells	NULL
in	NULL
the	NULL
cerebrospinal	NULL
fluid	NULL
.	NULL

Methotrexate	NULL
and	NULL
prednisolone	NULL
were	NULL
repeatedly	NULL
injected	NULL
intrathecally	NULL
,	NULL
resulting	NULL
in	NULL
improvement	NULL
of	NULL
the	NULL
neurological	NULL
symptoms	NULL
.	NULL

She	NULL
was	NULL
then	NULL
treated	NULL
with	NULL
high-dose	NULL
chemotherapy	NULL
with	NULL
autologous	NULL
hematopoietic	NULL
stem	NULL
cell	NULL
support	NULL
.	NULL

Shortly	NULL
after	NULL
recovery	NULL
of	NULL
hematopoiesis	NULL
,	NULL
the	NULL
skin	NULL
overlying	NULL
the	NULL
left	NULL
breast	NULL
was	NULL
infiltrated	NULL
;	NULL
she	NULL
refused	NULL
additional	NULL
treatment	NULL
and	NULL
was	NULL
dis-charged	NULL
.	NULL

In	NULL
November	NULL
1996	NULL
,	NULL
she	NULL
was	NULL
readmitted	NULL
due	NULL
to	NULL
a	NULL
huge	NULL
mass	NULL
of	NULL
the	NULL
right	NULL
axillary	NULL
region	NULL
and	NULL
the	NULL
florid	NULL
left	NULL
breast	NULL
tumor	NULL
.	NULL

She	NULL
has	NULL
been	NULL
treated	NULL
with	NULL
chemo-radiotherapy	NULL
in	NULL
addition	NULL
to	NULL
left	NULL
mastectomy	NULL
.	NULL

However	NULL
,	NULL
the	NULL
lymphoma	NULL
showed	NULL
leukemic	NULL
manifestations	NULL
and	NULL
she	NULL
died	NULL
19	NULL
months	NULL
after	NULL
the	NULL
initial	NULL
presentation	NULL
.	NULL

Hematopathological	NULL
findings	NULL
The	NULL
breast	NULL
tumors	NULL
in	NULL
both	NULL
cases	NULL
showed	NULL
diffuse	NULL
proliferation	NULL
of	NULL
large	NULL
lymphoid	NULL
cells	NULL
and	NULL
infiltration	NULL
to	NULL
surrounding	NULL
tissues	NULL
(	NULL
Figs	NULL
.	NULL

1	NULL
and	NULL
2A	NULL
)	NULL
.	NULL

Regional	NULL
lymph	NULL
nodes	NULL
of	NULL
case	NULL
2	NULL
were	NULL
composed	NULL
of	NULL
cells	NULL
with	NULL
nuclear	NULL
diameter	NULL
greater	NULL
than	NULL
the	NULL
admixed	NULL
£	NULL
*	NULL
ab	NULL
&	NULL
)	NULL
38	NULL
s	NULL
Figure	NULL
1.	NULL
stain	NULL
,	NULL
x180	NULL
)	NULL
.	NULL

The	NULL
lymphoma	NULL
cells	NULL
were	NULL
intermediate	NULL
to	NULL
large	NULL
in	NULL
size	NULL
.	NULL

Multinucleated	NULL
cells	NULL
were	NULL
occasionally	NULL
seen	NULL
.	NULL

Histopathology	NULL
of	NULL
the	NULL
breast	NULL
tumor	NULL
in	NULL
case	NULL
1	NULL
(	NULL
HE	NULL
312	NULL
starry	NULL
sky	NULL
'	NULL
macrophages	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Lymphoepithelial	NULL
lesions	NULL
or	NULL
plasmacytoid	NULL
differentiation	NULL
were	NULL
not	NULL
apparent	NULL
.	NULL

In	NULL
accordance	NULL
with	NULL
the	NULL
criteria	NULL
of	NULL
the	NULL
REAL	NULL
classification	NULL
(	NULL
6	NULL
)	NULL
,	NULL
the	NULL
two	NULL
lymphomas	NULL
were	NULL
categorized	NULL
as	NULL
diffuse	NULL
large	NULL
B-cell	NULL
lymphoma	NULL
.	NULL

Figure	NULL
3	NULL
shows	NULL
lymphoma	NULL
cells	NULL
in	NULL
the	NULL
peripheral	NULL
blood	NULL
.	NULL

The	NULL
cells	NULL
of	NULL
both	NULL
cases	NULL
had	NULL
basophilic	NULL
cytoplasm	NULL
containing	NULL
multiple	NULL
vacuoles	NULL
.	NULL

Nucleoli	NULL
were	NULL
prominent	NULL
.	NULL

Immunophenotyping	NULL
of	NULL
the	NULL
lymphoma	NULL
cells	NULL
Mononuclear	NULL
cells	NULL
were	NULL
isolated	NULL
from	NULL
the	NULL
peripheral	NULL
blood	NULL
of	NULL
case	NULL
1	NULL
by	NULL
Ficoll-Paque	NULL
density	NULL
gradient	NULL
centrifugation	NULL
.	NULL

Breast	NULL
tumors	NULL
from	NULL
case	NULL
2	NULL
were	NULL
finely	NULL
minced	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
and	NULL
cells	NULL
suspended	NULL
in	NULL
the	NULL
buffer	NULL
were	NULL
collected	NULL
.	NULL

Surface	NULL
immunophenotypes	NULL
of	NULL
these	NULL
specimens	NULL
were	NULL
determined	NULL
by	NULL
an	NULL
indirect	NULL
immunofluorescence	NULL
method	NULL
using	NULL
flow	NULL
cytometry	NULL
and	NULL
monoclonal	NULL
antibodies	NULL
.	NULL

As	NULL
summarized	NULL
in	NULL
Table	NULL
1	NULL
,	NULL
the	NULL
peripheral	NULL
blood	NULL
of	NULL
case	NULL
1	NULL
included	NULL
nearly	NULL
30	NULL
%	NULL
lymphoma	NULL
cells	NULL
expressing	NULL
the	NULL
CD19	NULL
,	NULL
CD20	NULL
,	NULL
HLA-DR	NULL
antigens	NULL
as	NULL
Figure	NULL
2	NULL
.	NULL

(	NULL
B	NULL
)	NULL
the	NULL
regional	NULL
lymph	NULL
node	NULL
(	NULL
x180	NULL
)	NULL
of	NULL
case	NULL
2	NULL
(	NULL
HE	NULL
stain	NULL
)	NULL
.	NULL

Lymphoma	NULL
cells	NULL
infiltrated	NULL
the	NULL
surrounding	NULL
adipose	NULL
and	NULL
connective	NULL
tissues	NULL
.	NULL

The	NULL
lymph	NULL
nodes	NULL
showed	NULL
diffuse	NULL
proliferation	NULL
of	NULL
large	NULL
cells	NULL
with	NULL
macrophage	NULL
infiltration	NULL
.	NULL

Histopathology	NULL
of	NULL
(	NULL
A	NULL
)	NULL
the	NULL
breast	NULL
tumor	NULL
(	NULL
x70	NULL
)	NULL
and	NULL
Internal	NULL
Medicine	NULL
Vol	NULL
.	NULL

37	NULL
,	NULL
No	NULL
.	NULL

3	NULL
(	NULL
March	NULL
1998	NULL
)	NULL
Lymphoma	NULL
of	NULL
Bilateral	NULL
Breasts	NULL
Figure	NULL
3	NULL
.	NULL

(	NULL
May-Giemsa	NULL
stain	NULL
,	NULL
900	NULL
)	NULL
.	NULL

Lymphoma	NULL
cells	NULL
in	NULL
the	NULL
peripheral	NULL
blood	NULL
of	NULL
case	NULL
1	NULL
well	NULL
as	NULL
1d/A	NULL
monoclonal	NULL
immunoglobulin	NULL
.	NULL

The	NULL
lymphoma	NULL
cells	NULL
of	NULL
case	NULL
2	NULL
showed	NULL
the	NULL
identical	NULL
mature	NULL
B-cell	NULL
immunophenotype	NULL
;	NULL
the	NULL
cells	NULL
partially	NULL
expressed	NULL
the	NULL
CD25	NULL
antigen	NULL
.	NULL

Both	NULL
lymphoma	NULL
cells	NULL
lacked	NULL
CDS	NULL
expression	NULL
.	NULL

Other	NULL
T-cell-	NULL
,	NULL
NK-cell-	NULL
,	NULL
granulocyte/macrophage-associated	NULL
markers	NULL
were	NULL
negative	NULL
.	NULL

State	NULL
of	NULL
oncogenes	NULL
and	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
genome	NULL
in	NULL
the	NULL
lymphoma	NULL
cells	NULL
Genomic	NULL
DNA	NULL
was	NULL
extracted	NULL
from	NULL
breast	NULL
tumors	NULL
and	NULL
subjected	NULL
to	NULL
molecular	NULL
analysis	NULL
to	NULL
determine	NULL
the	NULL
state	NULL
of	NULL
oncogenes	NULL
related	NULL
to	NULL
the	NULL
development	NULL
of	NULL
B-cell	NULL
NHL	NULL
.	NULL

Rearrangement	NULL
of	NULL
the	NULL
c-MYC	NULL
and	NULL
BCL2	NULL
genes	NULL
,	NULL
involved	NULL
in	NULL
t	NULL
(	NULL
8	NULL
;	NULL
14	NULL
)	NULL
(	NULL
q24	NULL
;	NULL
q32	NULL
)	NULL
and	NULL
t	NULL
(	NULL
14	NULL
;	NULL
18	NULL
)	NULL
(	NULL
q32	NULL
;	NULL
q21	NULL
)	NULL
translocations	NULL
,	NULL
respectively	NULL
,	NULL
were	NULL
studied	NULL
by	NULL
long-distance	NULL
polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
PCR	NULL
)	NULL
using	NULL
primer	NULL
pairs	NULL
designed	NULL
for	NULL
the	NULL
two	NULL
oncogenes	NULL
and	NULL
the	NULL
immunoglobulin	NULL
heavy	NULL
chain	NULL
(	NULL
IGH	NULL
)	NULL
gene	NULL
(	NULL
7	NULL
,	NULL
8	NULL
)	NULL
.	NULL

The	NULL
DNA	NULL
from	NULL
both	NULL
cases	NULL
was	NULL
negative	NULL
for	NULL
the	NULL
c-MYC/IGH	NULL
fusion	NULL
product	NULL
indicative	NULL
of	NULL
t	NULL
(	NULL
8	NULL
;	NULL
14	NULL
)	NULL
or	NULL
the	NULL
BCL2/IGH	NULL
fusion	NULL
of	NULL
t	NULL
(	NULL
14	NULL
;	NULL
18	NULL
)	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Rearrangement	NULL
of	NULL
the	NULL
BCLG	NULL
gene	NULL
on	NULL
chromosomal	NULL
band	NULL
3q27	NULL
was	NULL
studied	NULL
by	NULL
conventional	NULL
Southern	NULL
blot	NULL
analysis	NULL
using	NULL
a	NULL
probe	NULL
for	NULL
the	NULL
major	NULL
translocation	NULL
cluster	NULL
(	NULL
MTC	NULL
)	NULL
region	NULL
of	NULL
BCL6	NULL
(	NULL
9	NULL
,	NULL
10	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
DNA	NULL
from	NULL
both	NULL
patients	NULL
showed	NULL
rearrangements	NULL
of	NULL
this	NULL
gene	NULL
.	NULL

Cytogenetic	NULL
analysis	NULL
of	NULL
the	NULL
breast	NULL
tumor	NULL
obtained	NULL
from	NULL
case	NULL
2	NULL
,	NULL
with	NULL
the	NULL
knowledge	NULL
of	NULL
the	NULL
rearrangement	NULL
,	NULL
failed	NULL
to	NULL
identify	NULL
evident	NULL
involvement	NULL
of	NULL
the	NULL
3q27	NULL
region	NULL
due	NULL
to	NULL
poor	NULL
metaphase	NULL
quality	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
the	NULL
EBV	NULL
genome	NULL
was	NULL
studied	NULL
by	NULL
PCR	NULL
amplification	NULL
of	NULL
the	NULL
EBV-encoded	NULL
small	NULL
RNA	NULL
region	NULL
(	NULL
11	NULL
)	NULL
,	NULL
using	NULL
DNA	NULL
from	NULL
African	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
(	NULL
BL	NULL
)	NULL
-derived	NULL
cell	NULL
lines	NULL
as	NULL
the	NULL
control	NULL
.	NULL

The	NULL
DNA	NULL
from	NULL
both	NULL
cases	NULL
showed	NULL
no	NULL
amplification	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Discussion	NULL
Literature	NULL
reviews	NULL
of	NULL
PBL	NULL
have	NULL
indicated	NULL
that	NULL
there	NULL
are	NULL
two	NULL
distinct	NULL
clinicopathological	NULL
subtypes	NULL
(	NULL
2	NULL
,	NULL
5	NULL
)	NULL
:	NULL
the	NULL
unilateral	NULL
subtype	NULL
Internal	NULL
Medicine	NULL
Vol	NULL
.	NULL

37	NULL
,	NULL
No	NULL
.	NULL

3	NULL
(	NULL
March	NULL
1998	NULL
)	NULL
Table	NULL
1	NULL
.	NULL

Surface	NULL
Immunophenotype	NULL
of	NULL
Lymphoma	NULL
Cells	NULL
Positive	NULL
cells	NULL
(	NULL
%	NULL
)	NULL
Antigens	NULL
Case	NULL
1	NULL
Case	NULL
2	NULL
(	NULL
peripheral	NULL
blood	NULL
)	NULL
(	NULL
breast	NULL
tumor	NULL
)	NULL
CD3	NULL
61.9	NULL
7.7	NULL
CD4	NULL
34.8	NULL
1.3	NULL
CDS	NULL
68.3	NULL
8.4	NULL
CD7	NULL
61.6	NULL
9.8	NULL
CD8	NULL
22.7	NULL
6.5	NULL
CD10	NULL
0.8	NULL
3.0	NULL
CD19	NULL
27.3	NULL
91.6	NULL
CD20	NULL
28.1	NULL
92.6	NULL
CD16	NULL
12.2	NULL
0.9	NULL
CD56	NULL
12.8	NULL
0.5	NULL
CD14	NULL
1.5	NULL
0.7	NULL
CD13	NULL
1.3	NULL
1.2	NULL
CD33	NULL
1.6	NULL
0.9	NULL
CD25	NULL
not	NULL
tested	NULL
25.3	NULL
HLA-DR	NULL
62.2	NULL
79.7	NULL
sIgM	NULL
26.6	NULL
90.9	NULL
sIgD	NULL
25.3	NULL
88.9	NULL
sIgG	NULL
0.6	NULL
0.4	NULL
sIgA	NULL
1.1	NULL
0.1	NULL
slgx	NULL
7.0	NULL
0.1	NULL
sig	NULL
21.2	NULL
89.5	NULL
slg	NULL
:	NULL
surface	NULL
immunoglobulin	NULL
.	NULL

that	NULL
shows	NULL
indolent	NULL
to	NULL
aggressive	NULL
histology	NULL
and	NULL
mimics	NULL
breast	NULL
carcinoma	NULL
in	NULL
age	NULL
distribution	NULL
,	NULL
and	NULL
the	NULL
bilateral	NULL
subtype	NULL
affecting	NULL
pregnant	NULL
or	NULL
lactating	NULL
women	NULL
.	NULL

The	NULL
latter	NULL
group	NULL
is	NULL
further	NULL
characterized	NULL
by	NULL
widespread	NULL
dissemination	NULL
with	NULL
prominent	NULL
ovarian	NULL
and	NULL
central	NULL
nervous	NULL
system	NULL
involvement	NULL
,	NULL
and	NULL
characteristic	NULL
histological	NULL
findings	NULL
identical	NULL
to	NULL
those	NULL
of	NULL
BL	NULL
have	NULL
been	NULL
reported	NULL
in	NULL
African	NULL
women	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
described	NULL
two	NULL
patients	NULL
with	NULL
PBL	NULL
involving	NULL
the	NULL
bilateral	NULL
breasts	NULL
and	NULL
their	NULL
characteristics	NULL
are	NULL
summarized	NULL
in	NULL
Table	NULL
2	NULL
.	NULL

Both	NULL
patients	NULL
were	NULL
younger	NULL
than	NULL
the	NULL
median	NULL
age	NULL
for	NULL
NHL	NULL
.	NULL

Case	NULL
2	NULL
was	NULL
pregnant	NULL
at	NULL
the	NULL
time	NULL
of	NULL
presentation	NULL
.	NULL

Bilateral	NULL
tumors	NULL
occurred	NULL
concurrently	NULL
in	NULL
case	NULL
2	NULL
,	NULL
whereas	NULL
in	NULL
case	NULL
1	NULL
the	NULL
second	NULL
tumor	NULL
of	NULL
the	NULL
contralateral	NULL
breast	NULL
appeared	NULL
17	NULL
months	NULL
after	NULL
the	NULL
first	NULL
mastectomy	NULL
.	NULL

Both	NULL
patients	NULL
developed	NULL
progressive	NULL
disease	NULL
despite	NULL
chemo-radiotherapy	NULL
and	NULL
died	NULL
of	NULL
leukemic	NULL
mani-festations	NULL
.	NULL

In	NULL
case	NULL
1	NULL
,	NULL
no	NULL
other	NULL
organs	NULL
except	NULL
for	NULL
the	NULL
axillary	NULL
lymph	NULL
nodes	NULL
were	NULL
involved	NULL
during	NULL
the	NULL
course	NULL
of	NULL
the	NULL
disease	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
case	NULL
2	NULL
had	NULL
rapidly	NULL
growing	NULL
bilateral	NULL
tumors	NULL
as	NULL
well	NULL
as	NULL
systemic	NULL
dissemination	NULL
at	NULL
the	NULL
initial	NULL
presentation	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
disease	NULL
had	NULL
characteristic	NULL
features	NULL
of	NULL
the	NULL
bilateral	NULL
subtype	NULL
;	NULL
indeed	NULL
,	NULL
the	NULL
lymph	NULL
nodes	NULL
showed	NULL
packed	NULL
proliferation	NULL
of	NULL
large	NULL
cells	NULL
with	NULL
macrophage	NULL
infiltration	NULL
,	NULL
suggesting	NULL
high	NULL
grade	NULL
histopathology	NULL
.	NULL

However	NULL
,	NULL
the	NULL
tumor	NULL
lacked	NULL
molecular	NULL
evidence	NULL
of	NULL
t	NULL
(	NULL
8	NULL
;	NULL
14	NULL
)	NULL
which	NULL
has	NULL
been	NULL
observed	NULL
in	NULL
85	NULL
%	NULL
of	NULL
BL	NULL
(	NULL
13	NULL
)	NULL
,	NULL
although	NULL
our	NULL
method	NULL
may	NULL
have	NULL
missed	NULL
its	NULL
variant	NULL
,	NULL
t	NULL
(	NULL
2	NULL
;	NULL
8	NULL
)	NULL
(	NULL
p12	NULL
;	NULL
q24	NULL
)	NULL
or	NULL
(	NULL
8	NULL
;	NULL
22	NULL
)	NULL
(	NULL
q24	NULL
;	NULL
q1	NULL
1	NULL
)	NULL
.	NULL

It	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
whether	NULL
the	NULL
c	NULL
313	NULL
Enzyme	NULL
:	NULL
EcoRI	NULL
Case	NULL
1	NULL
KrrawaAK1I	NULL
et	NULL
al	NULL
Case	NULL
1	NULL
Xbal	NULL
od	NULL
o	NULL
%	NULL
t	NULL
O	NULL
O	NULL
U	NULL
O	NULL
-._	NULL
__	NULL
'	NULL
<	NULL
BamHI	NULL
Xbal	NULL
Probe	NULL
:	NULL
BCL6	NULL
MTC	NULL
probe	NULL
Figure	NULL
4	NULL
.	NULL

-	NULL
Southern	NULL
blot	NULL
hybridization	NULL
showing	NULL
rearrangement	NULL
of	NULL
the	NULL
BCL6	NULL
gene	NULL
.	NULL

Genomic	NULL
DNA	NULL
extracted	NULL
from	NULL
breast	NULL
tumors	NULL
from	NULL
the	NULL
two	NULL
cases	NULL
were	NULL
digested	NULL
with	NULL
the	NULL
restriction	NULL
enzymes	NULL
indicated	NULL
,	NULL
and	NULL
hybridized	NULL
with	NULL
the	NULL
F372	NULL
probe	NULL
representing	NULL
the	NULL
MTC	NULL
region	NULL
of	NULL
BCL6	NULL
gene	NULL
(	NULL
9	NULL
,	NULL
10	NULL
)	NULL
.	NULL

C	NULL
lanes	NULL
are	NULL
germline	NULL
control	NULL
.	NULL

Rearranged	NULL
bands	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

HindlIlI-digested	NULL
A	NULL
phage	NULL
DNA	NULL
was	NULL
used	NULL
as	NULL
a	NULL
molecular	NULL
standard	NULL
.	NULL

Table	NULL
2	NULL
.	NULL

Summary	NULL
of	NULL
Characteristics	NULL
of	NULL
the	NULL
Two	NULL
Patients	NULL
Case	NULL
1	NULL
Case	NULL
2	NULL
Age/Sex	NULL
42/female	NULL
35/female	NULL
(	NULL
pregnant	NULL
)	NULL
Lymphoma	NULL
of	NULL
the	NULL
breast	NULL
Bilateral	NULL
Bilateral	NULL
17	NULL
mo	NULL
.	NULL

interval	NULL
(	NULL
right-left	NULL
)	NULL
Concurrent	NULL
(	NULL
right	NULL
>	NULL
left	NULL
)	NULL
Histology/phenotype	NULL
Molecular	NULL
genetics	NULL
Stage	NULL
at	NULL
initial	NULL
presentation	NULL
Other	NULL
involved	NULL
organs	NULL
Therapy	NULL
Outcome/Survival	NULL
Diffuse	NULL
large/B-cell	NULL
BCL6	NULL
rearrangement	NULL
Stage	NULL
I	NULL
Leukemic	NULL
Bilateral	NULL
mastectomy	NULL
Standard	NULL
chemotherapy	NULL
Radiation	NULL
Relapsed	NULL
,	NULL
refractory/	NULL
24	NULL
months	NULL
,	NULL
dead	NULL
Diffuse	NULL
large/B-cell	NULL
BCL6	NULL
rearrangement	NULL
Stage	NULL
IV	NULL
Cerebrospinal	NULL
fluid	NULL
,	NULL
ovary	NULL
,	NULL
uterus	NULL
,	NULL
bone	NULL
,	NULL
lymph	NULL
nodes	NULL
,	NULL
skin	NULL
,	NULL
leukemic	NULL
Bilateral	NULL
mastectomy	NULL
High-dose	NULL
chemotherapy	NULL
Radiation	NULL
Relapsed	NULL
,	NULL
refractory/	NULL
19	NULL
months	NULL
,	NULL
dead	NULL
314	NULL
Internal	NULL
Medicine	NULL
Vol	NULL
.	NULL

37	NULL
,	NULL
No	NULL
.	NULL

3	NULL
(	NULL
March	NULL
1998	NULL
)	NULL
Lymphoma	NULL
of	NULL
Bilateral	NULL
Breasts	NULL
MYC	NULL
gene	NULL
is	NULL
deregulated	NULL
in	NULL
this	NULL
particular	NULL
type	NULL
of	NULL
PBL	NULL
.	NULL

PBL	NULL
has	NULL
been	NULL
suggested	NULL
to	NULL
be	NULL
an	NULL
extranodal	NULL
lymphoma	NULL
of	NULL
the	NULL
mucosa-associated	NULL
lymphoid	NULL
tissues	NULL
(	NULL
MALT	NULL
)	NULL
(	NULL
1-5	NULL
)	NULL
.	NULL

However	NULL
,	NULL
histopathological	NULL
observation	NULL
of	NULL
the	NULL
present	NULL
cases	NULL
failed	NULL
to	NULL
identify	NULL
characteristic	NULL
features	NULL
of	NULL
lymphomas	NULL
of	NULL
MALT	NULL
type	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
both	NULL
cases	NULL
had	NULL
BCLG	NULL
rearrangements	NULL
as	NULL
common	NULL
genetic	NULL
lesions	NULL
,	NULL
which	NULL
have	NULL
been	NULL
mainly	NULL
observed	NULL
in	NULL
diffuse	NULL
large	NULL
B-cell	NULL
lymphoma	NULL
(	NULL
10	NULL
,	NULL
14	NULL
)	NULL
.	NULL

In	NULL
our	NULL
initial	NULL
study	NULL
(	NULL
15	NULL
)	NULL
,	NULL
MALT	NULL
lymphoma	NULL
with	NULL
low	NULL
grade	NULL
histology	NULL
occurring	NULL
in	NULL
other	NULL
MALT	NULL
sites	NULL
showed	NULL
germline	NULL
configuration	NULL
of	NULL
BCL6	NULL
,	NULL
and	NULL
t	NULL
(	NULL
11	NULL
;	NULL
18	NULL
)	NULL
(	NULL
q21	NULL
;	NULL
q21.1	NULL
)	NULL
has	NULL
been	NULL
reported	NULL
as	NULL
a	NULL
potential	NULL
specific	NULL
translocation	NULL
of	NULL
MALT	NULL
type	NULL
NHL	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
was	NULL
suggested	NULL
that	NULL
the	NULL
two	NULL
PBL	NULL
presented	NULL
here	NULL
were	NULL
not	NULL
of	NULL
MALT	NULL
origin	NULL
but	NULL
de	NULL
novo	NULL
diffuse	NULL
large	NULL
B-cell	NULL
lymphoma	NULL
.	NULL

It	NULL
remains	NULL
to	NULL
be	NULL
elucidated	NULL
why	NULL
the	NULL
current	NULL
lymphomas	NULL
preferentially	NULL
involved	NULL
the	NULL
breast	NULL
tissues	NULL
.	NULL

Acknowledgements	NULL
:	NULL
The	NULL
authors	NULL
wish	NULL
to	NULL
thank	NULL
Drs	NULL
.	NULL

H.	NULL
Kodama	NULL
and	NULL
K.	NULL
Yamauchi	NULL
of	NULL
the	NULL
surgery	NULL
department	NULL
for	NULL
their	NULL
valuable	NULL
suggestions	NULL
.	NULL

Histopathological	NULL
diagnosis	NULL
was	NULL
made	NULL
by	NULL
Drs	NULL
.	NULL

Y.	NULL
Nakashima	NULL
and	NULL
H.	NULL
Yamabe	NULL
.	NULL

Cell	NULL
marker	NULL
analysis	NULL
by	NULL
flow	NULL
cytometry	NULL
was	NULL
performed	NULL
by	NULL
Dr.	NULL
K.	NULL
Obhmori	NULL
.	NULL

References	NULL
1	NULL
)	NULL
-	NULL
Lamovec	NULL
J	NULL
,	NULL
Jancar	NULL
J	NULL
.	NULL

Primary	NULL
malignant	NULL
lymphoma	NULL
of	NULL
the	NULL
breast	NULL
:	NULL
lymphoma	NULL
of	NULL
the	NULL
mucosa-associated	NULL
lymphoid	NULL
tissue	NULL
.	NULL

Cancer	NULL
60	NULL
:	NULL
3033	NULL
,	NULL
1	NULL
987	NULL
.	NULL

2	NULL
)	NULL
Hugh	NULL
JC	NULL
,	NULL
Jackson	NULL
FI	NULL
,	NULL
Hanson	NULL
J	NULL
,	NULL
Poppema	NULL
S.	NULL
Primary	NULL
breast	NULL
lymphoma	NULL
:	NULL
an	NULL
immunohistologic	NULL
study	NULL
of	NULL
20	NULL
new	NULL
cases	NULL
.	NULL

Cancer	NULL
66	NULL
:	NULL
2602	NULL
,	NULL
1990	NULL
.	NULL

3	NULL
)	NULL
-	NULL
Cohen	NULL
PL	NULL
,	NULL
Brooks	NULL
JJ	NULL
.	NULL

Lymphomas	NULL
of	NULL
the	NULL
breast	NULL
:	NULL
a	NULL
clinicopathologic	NULL
and	NULL
immunohistochemical	NULL
study	NULL
of	NULL
primary	NULL
and	NULL
secondary	NULL
cases	NULL
.	NULL

Cancer	NULL
67	NULL
:	NULL
1359	NULL
,	NULL
1991	NULL
.	NULL

4	NULL
)	NULL
Aozasa	NULL
K	NULL
,	NULL
Ohsawa	NULL
M	NULL
,	NULL
Saeki	NULL
K	NULL
,	NULL
Horiuchi	NULL
K	NULL
,	NULL
Kawano	NULL
K	NULL
,	NULL
Taguchi	NULL
T.	NULL
Malignant	NULL
lymphoma	NULL
of	NULL
the	NULL
breast	NULL
:	NULL
immunologic	NULL
type	NULL
and	NULL
association	NULL
with	NULL
lymphocytic	NULL
mastopathy	NULL
.	NULL

Am	NULL
J	NULL
Clin	NULL
Pathol	NULL
97	NULL
:	NULL
699	NULL
,	NULL
1992	NULL
.	NULL

5	NULL
)	NULL
Jeon	NULL
HJ	NULL
,	NULL
Akagi	NULL
T	NULL
,	NULL
Hoshida	NULL
Y	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Primary	NULL
non-Hodgkin	NULL
malignant	NULL
lymphoma	NULL
of	NULL
the	NULL
breast	NULL
:	NULL
an	NULL
immunohistochemical	NULL
study	NULL
of	NULL
seven	NULL
patients	NULL
and	NULL
literature	NULL
review	NULL
of	NULL
152	NULL
patients	NULL
with	NULL
breast	NULL
lymphoma	NULL
in	NULL
Japan	NULL
.	NULL

Cancer	NULL
70	NULL
;	NULL
2451	NULL
,	NULL
1992	NULL
.	NULL

6	NULL
)	NULL
Harris	NULL
NL	NULL
,	NULL
Jaffe	NULL
ES	NULL
,	NULL
Stein	NULL
H	NULL
,	NULL
et	NULL
al	NULL
.	NULL

A	NULL
revised	NULL
European-American	NULL
classification	NULL
of	NULL
lymphoid	NULL
neoplasms	NULL
:	NULL
A	NULL
proposal	NULL
from	NULL
the	NULL
International	NULL
Lymphoma	NULL
Study	NULL
Group	NULL
.	NULL

Blood	NULL
84	NULL
:	NULL
1361	NULL
,	NULL
1994	NULL
.	NULL

7	NULL
)	NULL
Akasaka	NULL
T	NULL
,	NULL
Akasaka	NULL
H	NULL
,	NULL
Yonetani	NULL
N	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Refinement	NULL
of	NULL
the	NULL
BCL2/	NULL
immunoglobulin	NULL
fusion	NULL
gene	NULL
in	NULL
t	NULL
(	NULL
14	NULL
;	NULL
18	NULL
)	NULL
(	NULL
q32	NULL
;	NULL
q21	NULL
)	NULL
by	NULL
polymerase	NULL
chain	NULL
reaction	NULL
amplification	NULL
for	NULL
long	NULL
targets	NULL
.	NULL

Genes	NULL
,	NULL
Chromosomes	NULL
Cancer	NULL
21	NULL
:	NULL
17	NULL
,	NULL
1998	NULL
.	NULL

8	NULL
)	NULL
-	NULL
Akasaka	NULL
T	NULL
,	NULL
Muramatsu	NULL
M	NULL
,	NULL
Ohno	NULL
H	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Application	NULL
of	NULL
long-distance	NULL
polymerase	NULL
chain	NULL
reaction	NULL
to	NULL
detection	NULL
of	NULL
junctional	NULL
sequences	NULL
created	NULL
by	NULL
chromosomal	NULL
translocation	NULL
in	NULL
mature	NULL
B-cell	NULL
neoplasms	NULL
.	NULL

Blood	NULL
88	NULL
:	NULL
985	NULL
,	NULL
1996	NULL
.	NULL

9	NULL
)	NULL
Deweindt	NULL
C	NULL
,	NULL
Kerckaert	NULL
JP	NULL
,	NULL
Tilly	NULL
H	NULL
,	NULL
Quief	NULL
S	NULL
,	NULL
Nguyen	NULL
VC	NULL
,	NULL
Bastard	NULL
C.	NULL
Cloning	NULL
of	NULL
a	NULL
breakpoint	NULL
cluster	NULL
region	NULL
at	NULL
band	NULL
3q27	NULL
involved	NULL
in	NULL
human	NULL
non-Hodgkin	NULL
's	NULL
lymphoma	NULL
.	NULL

Genes	NULL
,	NULL
Chromosomes	NULL
Cancer	NULL
8	NULL
:	NULL
149	NULL
,	NULL
1993	NULL
.	NULL

Muramatsu	NULL
M	NULL
,	NULL
Akasaka	NULL
T	NULL
,	NULL
Kadowaki	NULL
N	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Rearrangement	NULL
of	NULL
the	NULL
BCL6	NULL
gene	NULL
in	NULL
B-cell	NULL
lymphoid	NULL
neoplasms	NULL
:	NULL
comparison	NULL
with	NULL
lymphomas	NULL
associated	NULL
with	NULL
BCL2	NULL
rearrangement	NULL
.	NULL

Br	NULL
J	NULL
Haematol	NULL
93	NULL
:	NULL
911	NULL
,	NULL
1996	NULL
.	NULL

Frank	NULL
D	NULL
,	NULL
Cesarman	NULL
E	NULL
,	NULL
Lin	NULL
YF	NULL
,	NULL
Michler	NULL
RE	NULL
,	NULL
Knowles	NULL
DM	NULL
.	NULL

Post	NULL
transplantation	NULL
lymphoproliferative	NULL
disorders	NULL
frequently	NULL
contain	NULL
type	NULL
A	NULL
and	NULL
not	NULL
type	NULL
B	NULL
Epstein-Barr	NULL
virus	NULL
.	NULL

Blood	NULL
85	NULL
:	NULL
1396	NULL
,	NULL
1995	NULL
.	NULL

Shepherd	NULL
JJ	NULL
,	NULL
Wright	NULL
DH	NULL
.	NULL

Burkitt	NULL
's	NULL
tumour	NULL
presenting	NULL
as	NULL
bilateral	NULL
swell	NULL
ing	NULL
of	NULL
the	NULL
breast	NULL
in	NULL
women	NULL
of	NULL
child-bearing	NULL
age	NULL
.	NULL

Br	NULL
J	NULL
Surg	NULL
54	NULL
:	NULL
776	NULL
,	NULL
1967	NULL
.	NULL

Nowell	NULL
PC	NULL
,	NULL
Croce	NULL
CM	NULL
.	NULL

Chromosome	NULL
translocations	NULL
and	NULL
oncogenes	NULL
in	NULL
human	NULL
lymphoid	NULL
tumors	NULL
.	NULL

Am	NULL
J	NULL
Clin	NULL
Pathol	NULL
94	NULL
;	NULL
229	NULL
,	NULL
1990	NULL
.	NULL

Bastard	NULL
C	NULL
,	NULL
Deweindt	NULL
C	NULL
,	NULL
Kerckaert	NULL
JP	NULL
,	NULL
et	NULL
al	NULL
.	NULL

LAZ3	NULL
rearrangements	NULL
in	NULL
non	NULL
Hodgkin	NULL
's	NULL
lymphoma	NULL
:	NULL
correlation	NULL
with	NULL
histology	NULL
,	NULL
immunophenotype	NULL
,	NULL
karyotype	NULL
,	NULL
and	NULL
clinical	NULL
outcome	NULL
in	NULL
217	NULL
patients	NULL
.	NULL

Blood	NULL
83	NULL
:	NULL
2423	NULL
,	NULL
1994	NULL
,	NULL
Ohno	NULL
H	NULL
,	NULL
Kerckaert	NULL
JP	NULL
,	NULL
Bastard	NULL
C	NULL
,	NULL
Fukuhara	NULL
S.	NULL
Heterogeneity	NULL
in	NULL
B-cell	NULL
neoplasms	NULL
associated	NULL
with	NULL
rearrangement	NULL
of	NULL
the	NULL
LAZ3	NULL
gene	NULL
on	NULL
chromo-	NULL
some	NULL
band	NULL
3q27	NULL
.	NULL

Jpn	NULL
J	NULL
Cancer	NULL
Res	NULL
85	NULL
:	NULL
592	NULL
,	NULL
1994	NULL
.	NULL

Horsman	NULL
D	NULL
,	NULL
Gascoyne	NULL
R	NULL
,	NULL
Klasa	NULL
R	NULL
,	NULL
Coupland	NULL
R.	NULL
t	NULL
(	NULL
11	NULL
;	NULL
18	NULL
)	NULL
(	NULL
q21	NULL
;	NULL
q21.1	NULL
)	NULL
:	NULL
a	NULL
recurring	NULL
translocation	NULL
in	NULL
lymphomas	NULL
of	NULL
mucosa-associated	NULL
lymphoid	NULL
tissue	NULL
(	NULL
MALT	NULL
)	NULL
?	NULL

Genes	NULL
,	NULL
Chromosomes	NULL
Cancer	NULL
4	NULL
:	NULL
183	NULL
,	NULL
1992	NULL
.	NULL

10	NULL
)	NULL
11	NULL
)	NULL
12	NULL
)	NULL
13	NULL
)	NULL
14	NULL
)	NULL
15	NULL
)	NULL
16	NULL
)	NULL
Internal	NULL
Medicine	NULL
Vol	NULL
.	NULL

37	NULL
,	NULL
No	NULL
.	NULL

3	NULL
(	NULL
March	NULL
1998	NULL
)	NULL
315	NULL

